Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dyslipidemia

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    July 2016
  1. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available


    June 2016
  2. SAHINER L, Asil S, Kaya EB, Ozer N, et al
    Percutaneous Implantation of the self-expanding valve Prosthesis a patient with homozygous familial hypercholesterolemia severe aortic stenosis and porcelain aorta.
    Int J Cardiol. 2016;220:661-664.
    PubMed     Text format     Abstract available


  3. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available


  4. WU AH, Gladden JD, Ahmed M, Ahmed A, et al
    Relation of serum uric acid to cardiovascular disease.
    Int J Cardiol. 2016;213:4-7.
    PubMed     Text format     Abstract available


    May 2016
  5. PLAKHT Y, Gilutz H, Shiyovich A
    Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project.
    Int J Cardiol. 2016;219:20-24.
    PubMed     Text format     Abstract available


    April 2016
  6. DI MINNO MN, Di Minno A, Ambrosino P, Songia P, et al
    Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.
    Int J Cardiol. 2016;217:1-6.
    PubMed     Text format     Abstract available


    March 2016
  7. MASCITELLI L, Goldstein MR
    Might ezetimibe be considered an expensive placebo?
    Int J Cardiol. 2016;207:48-9.
    PubMed     Text format    


    January 2016
  8. FUENTES F, Alcala-Diaz JF, Watts GF, Mata P, et al
    Diabetes, statins and FH.
    Int J Cardiol. 2016;203:575.
    PubMed     Text format    


  9. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    


  10. TANG L, Jiang L, Pan XD, Chen PP, et al
    Extremely severe aortic stenosis developed in a young female patient with underdiagnosis of homozygous familial hypercholesterolemia: An 8-year follow-up.
    Int J Cardiol. 2016;207:372-374.
    PubMed     Text format    


  11. FILIPPATOS TD, Elisaf MS
    Effects of ezetimibe/simvastatin combination on metabolic parameters.
    Int J Cardiol. 2016;202:273-4.
    PubMed     Text format    


  12. KOH KK, Oh PC, Sakuma I
    Reply to comment on: Effects of ezetimibe/simvastatin combination on metabolic parameters by Prof. Moses S Elisaf.
    Int J Cardiol. 2016;202:154-5.
    PubMed     Text format    


  13. YU Q, Su X, Liu E
    Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study.
    Int J Cardiol. 2016;202:954-5.
    PubMed     Text format    


  14. ZU L, Ren C, Pan B, Zhou B, et al
    Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells.
    Int J Cardiol. 2016;202:756-9.
    PubMed     Text format    


  15. OIKONOMOU E, Siasos G, Tousoulis D
    Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
    Int J Cardiol. 2016;202:586-8.
    PubMed     Text format    


    April 2015
  16. WATTS GF, Shaw JE, Pang J, Magliano DJ, et al
    Prevalence and treatment of familial hypercholesterolaemia in Australian communities.
    Int J Cardiol. 2015;185:69-71.
    PubMed     Text format    


  17. MACHADO VA, Fonseca FA, Fonseca HA, Malina DT, et al
    Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia.
    Int J Cardiol. 2015;184:570-2.
    PubMed     Text format    


    March 2015
  18. TOURNADRE A, Tatar Z, Pereira B, Chevreau M, et al
    Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
    Int J Cardiol. 2015;183:149-54.
    PubMed     Text format     Abstract available


  19. RUBINSTEIN AL, Irazola VE, Calandrelli M, Elorriaga N, et al
    Multiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay.
    Int J Cardiol. 2015;183:82-8.
    PubMed     Text format     Abstract available


  20. WEI Y, Guo H, The E, Che W, et al
    Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
    Int J Cardiol. 2015;182:469-75.
    PubMed     Text format     Abstract available


    February 2015
  21. CHEN CX, Hay JW
    Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Int J Cardiol. 2015;181:417-24.
    PubMed     Text format     Abstract available


    January 2015
  22. SHIH CH, Ou SY, Shih CJ, Chen YT, et al
    Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: a nationwide population-based study.
    Int J Cardiol. 2015;178:256-61.
    PubMed     Text format     Abstract available


  23. DE GONZALO-CALVO D, Llorente-Cortes V, Orbe J, Paramo JA, et al
    High triglyceride-low HDL cholesterol lipid profile is associated with a dysregulated gene expression in mononuclear leukocyte from hypercholesterolemic patients.
    Int J Cardiol. 2015;178:102-4.
    PubMed     Text format    


  24. HERMANNS MI, Grossmann V, Spronk HM, Schulz A, et al
    Distribution, genetic and cardiovascular determinants of FVIII:c - Data from the population-based Gutenberg Health Study.
    Int J Cardiol. 2015;187:166-74.
    PubMed     Text format     Abstract available


  25. KRINTUS M, Kozinski M, Boudry P, Lackner K, et al
    Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I.
    Int J Cardiol. 2015;187:256-63.
    PubMed     Text format     Abstract available


    September 2014
  26. ROTH EM, Taskinen MR, Ginsberg HN, Kastelein JJ, et al
    Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.
    Int J Cardiol. 2014;176:55-61.
    PubMed     Text format     Abstract available


    July 2014
  27. ZHAO X, Bu L, Qin S, Kong D, et al
    Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia.
    Int J Cardiol. 2014 Jul 6. pii: S0167-5273(14)01170.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: